MetLife profit rises marginally on investment gains, strong underwriting
Reuters
Published Feb 03, 2021 04:20PM ET
Updated Feb 03, 2021 05:55PM ET
(Reuters) - Insurer MetLife Inc (NYSE:MET) reported a marginal rise in fourth-quarter adjusted profit on Wednesday as investment growth and underwriting gains in some of its U.S. businesses cushioned the hit from coronavirus-related claims.
MetLife reported adjusted earnings of $1.84 billion, or $2.03 per share, beating analysts' average estimates of $1.52 a share, according to Refinitiv IBES data.
Variable investment income totaled $778 million in the quarter, nearly all from private-equity investments.
MetLife earned $1.126 billion in such income for the full year, topping the target of $900 million to $1.1 billion it set a year ago.
On underwriting, payouts for dental and other non-medical health claims were lower, cushioning the effect of higher claims from life insurance caused by COVID-19-related deaths, the company said.
Adjusted earnings of the insurer's U.S. business jumped 51% to $1.02 billion, while the company's overall net investment income grew by 13% to $5.24 billion on strong returns from private equity investments.
That helped MetLife offset weak performance in Latin America, where its business was impacted by claims from deaths linked to the COVID-19 pandemic.
Global life insurers are taking steps to curb payouts stemming from the health crisis, including long-term health consequences that are not fully understood.nL1N2JP1SV]
In the United States, 8% of reported group life insurance claims from April to August attributed the cause of death to COVID-19, according to the U.S. Society of Actuaries.
MetLife also said its net derivative losses widened 7% from a year earlier to $1.56 billion.
The insurer holds a book of derivatives to hedge against the risk of market swings. Such gains do not indicate the actual performance of the company, but reflect the effect of accounting rules, an issue that has occurred in some previous quarters.
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.